For: | Kanda T, Sasaki R, Masuzaki R, Moriyama M. Artificial intelligence and machine learning could support drug development for hepatitis A virus internal ribosomal entry sites. Artif Intell Gastroenterol 2021; 2(1): 1-9 [DOI: 10.35712/aig.v2.i1.1] |
---|---|
URL: | https://www.wjgnet.com/2644-3236/full/v2/i1/1.htm |
Number | Citing Articles |